Delivery Order SPE2DB20D1047-SPE2DB25FF39E
Award Date
1/27/25
Potential Completion Date
1/28/25
Potential Value
$17K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,525.37, is for the delivery of ADBRY 150 MG/ML SYRINGEML, a pharmaceutical product. This is a Firm Fixed Price delivery order contract with an ultimate completion date of May 9, 2023. The contract is not designated with a set-aside, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,041.76 firm fixed-price contract is for the supply of ADBRY 150 MG/ML syringes and has an ultimate completion date of February 4, 2025. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $31,627.00 and a period of performance through May 30, 2024. It is for the procurement of ADBRY 150 MG/ML SYRINGEML, a pharmaceutical product. The contract is a firm fixed-price, delivery order, and does not have a set-aside designation. AmerisourceBergen holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of a pharmaceutical product, ADBRY 150 MG/ML SYRINGEML. The contract has a ceiling value of $12,125.82 and an ultimate completion date of August 30, 2024. It is a firm fixed-price contract and does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award. The company holds several Indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of ADBRY 150 MG/ML SYRINGE/ML pharmaceutical products. The contract has a potential value of $3,090.66 and a completion date of February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation. The contract is part of a larger indefinite delivery contract (IDC) awarded...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of a pharmaceutical product - ADBRY 150 MG/ML SYRINGEML. The order has a ceiling value of $17,638.32 and a period of performance through August 13, 2024. It is issued under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical valued at up to $999,999,999, which provides a broad range of medical commodities to support military...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, with a ceiling value of $6,332.74, is a delivery order for the medical product ADBRY 150 MG/ML SYRINGEML. It is a firm fixed price contract with a period of performance through February 27, 2025. This contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $3,028.98 contract is for the delivery of ADBRY 150 MG/ML SYRINGEML pharmaceutical products to support military treatment programs and facilities. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the supply of ADBRY 150 MG/ML SYRINGEML, a pharmaceutical product. The contract has a ceiling value of $5,538.17 and is a firm fixed price contract with a completion date of September 17, 2024. The contract is not set aside for any particular business type. As a major pharmaceutical distributor, AmerisourceBergen has been awarded numerous federal contracts by various...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,980.96 firm fixed price delivery order covers the supply of ADBRY 150 MG/ML SYRINGEML, a medical product, with an ultimate completion date of December 3, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...